Furthermore, we also found lower TGFB2 expression in RA-ILD patients who had circulating anti-CCP antibodies, which are associated with a higher incidence of ILD in RA and its progression to more severe forms [45]. This evidence concerns the gene TGFB2 and rheumatoid arthritis.